EyeGene Inc. (KOSDAQ:185490)
South Korea
· Delayed Price · Currency is KRW
2,720.00
+210.00 (8.37%)
At close: Mar 28, 2025, 3:30 PM KST
EyeGene Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Apr '25 Apr 2, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 81,495 | 69,196 | 91,605 | 108,036 | 408,921 | 148,527 | |
| Market Cap Growth | -24.46% | -24.46% | -15.21% | -73.58% | 175.32% | 11.93% | |
| Enterprise Value | 53,482 | 38,542 | 52,919 | 41,816 | 313,462 | 127,760 | |
| Last Close Price | 3015.00 | 2560.00 | 4265.00 | 5030.00 | 19100.00 | 9668.54 | |
| PS Ratio | 24.27 | 20.62 | 29.31 | 20.41 | 126.13 | 44.16 | |
| PB Ratio | 1.62 | 1.32 | 1.40 | 1.57 | 4.60 | 11.51 | |
| P/TBV Ratio | 1.50 | 1.50 | 1.47 | 1.64 | 4.64 | 11.97 | |
| EV/Sales Ratio | 15.94 | 11.49 | 16.93 | 7.90 | 96.68 | 37.99 | |
| Debt / Equity Ratio | 0.05 | 0.05 | 0.03 | 0.04 | 0.04 | 1.33 | |
| Asset Turnover | 0.05 | 0.05 | 0.04 | 0.06 | 0.04 | 0.07 | |
| Inventory Turnover | 6.90 | 6.90 | 4.56 | 4.10 | 2.40 | 3.59 | |
| Quick Ratio | 3.64 | 3.64 | 6.81 | 13.79 | 8.99 | 3.92 | |
| Current Ratio | 3.75 | 3.75 | 6.88 | 13.99 | 9.23 | 4.26 | |
| Return on Equity (ROE) | -21.89% | -21.89% | -33.39% | -33.55% | -67.87% | -93.10% | |
| Return on Assets (ROA) | -11.55% | -11.55% | -21.36% | -16.24% | -29.28% | -18.63% | |
| Return on Capital (ROIC) | -13.54% | -13.54% | -24.38% | -18.33% | -35.59% | -25.42% | |
| Earnings Yield | -14.88% | -17.53% | -23.04% | -24.02% | -8.45% | -10.01% | |
| FCF Yield | -16.79% | -19.78% | -23.48% | -17.90% | -7.92% | -7.94% | |
| Buyback Yield / Dilution | -24.78% | -24.78% | -0.95% | -13.22% | -36.98% | -3.62% | |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.